BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 21623114)

  • 21. Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.
    Komatsu M; Hanamura N; Tsuchiya S; Seki T; Kuroda T
    Radiat Med; 1994; 12(6):293-9. PubMed ID: 7724824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Parotid gland oncocytoma associated with papillary carcinoma of the thyroid gland (scintigraphic and anatomo-pathological study)].
    Macrí C; Terrible V; Mastrogiacomo I
    Pathologica; 1975; 67(967-968):195-204. PubMed ID: 1219580
    [No Abstract]   [Full Text] [Related]  

  • 23. [Morphometric analysis of the degree of thyrocyte aggregation in the preoperative diagnosis of thyroid cancer].
    Kirillov VA; Iushchenko IuP
    Klin Lab Diagn; 1996; (4):13-6. PubMed ID: 8963549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The demise of follicular carcinoma of the thyroid gland.
    LiVolsi VA; Asa SL
    Thyroid; 1994; 4(2):233-6. PubMed ID: 7920009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitfalls in the diagnosis of papillary carcinoma of the thyroid.
    Kulacoglu S; Ashton-Key M; Buley I
    Cytopathology; 1998 Jun; 9(3):193-200. PubMed ID: 9638381
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Our experience in diagnosis of cold nodules of the thyroid by means of thin-needle biopsy].
    Abate S; Palombini L; Ferulano GP; Vetrani A; Fresini A; Salvati AM
    Minerva Med; 1980 Jun; 71(23):1633-8. PubMed ID: 7383414
    [No Abstract]   [Full Text] [Related]  

  • 29. Fine needle aspirates of follicular lesions of the thyroid gland. The intermediate-type smear.
    Ravinsky E; Safneck JR
    Acta Cytol; 1990; 34(6):813-20. PubMed ID: 2256417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphometric image analysis of follicular lesions of the thyroid.
    Rajesh L; Saha M; Radhika S; Das Radotra B; Rajwanshi A
    Anal Quant Cytol Histol; 2004 Apr; 26(2):117-20. PubMed ID: 15131901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of thyroid disease.
    Aslam R; Steward D
    Otolaryngol Clin North Am; 2010 Apr; 43(2):273-83, viii. PubMed ID: 20510714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between chronic lymphocytic thyroiditis and thyroid tumors.
    Tamimi DM
    Int J Surg Pathol; 2002 Apr; 10(2):141-6. PubMed ID: 12075407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quantification of nucleolar organizers in thyroid tumors].
    Sellami NK; Ben Romdhane K; Chadli AD; Marrakchi R; Ben Ayed M
    Tunis Med; 1990 Oct; 68(10):603-6. PubMed ID: 2288027
    [No Abstract]   [Full Text] [Related]  

  • 36. [Critical reflections on differentiated carcinoma of the thyroid: difficulties, doubts and differential-diagnosis problems].
    Autelitano F; Spagnoli LG; Santeusanio G; Villaschi S; Autelitano M
    Ann Ital Chir; 1989; 60(4):267-80; discussion 280-1. PubMed ID: 2699711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
    Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
    Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid papillary carcinoma. Pathological and philosophical controversies.
    Vickery AL
    Am J Surg Pathol; 1983 Dec; 7(8):797-807. PubMed ID: 6660352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary cancer of the thyroid: natural history and therapy principles].
    Veroux P; Fazzi C; Nicosia AS; Veroux M; Cannizzaro MA
    Chir Ital; 1997; 49(1-2):15-27. PubMed ID: 12743871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differentiated thyroid gland carcinomas in "autonomous adenomas" in childhood].
    Müller A; Goretzki P; Witte J; Gerharz P; Röher HD
    Chirurg; 1995 Oct; 66(10):1018-20. PubMed ID: 8529444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.